Plus   Neg

Verastem Inc. (VSTM) Surged To A New High On Study Results

Verastem Inc. (VSTM) announced Saturday that data from studies of duvelisib were presented at the 23rd Congress of the European Hematology Association that was held in Stockholm, Sweden.

Verastem gapped up at the open Monday and climbed for the bulk of the session. The stock ended the day with a gain of 2.05 at $8.58 on the highest volume in 9 months. Verastem surged to a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT